PAK BioSolutions Founded
Fairfax, VA, October 5, 2018 – PAK BioSolutions, Inc. was recently founded and today welcomes on board Vice-President and co-founder Kevin Hill-Byrne. The company’s mission is to provide comprehensive solutions for end-to-end continuous manufacture of biopharmaceuticals with increased productivity, lower capital costs and a smaller footprint. The company will offer automated systems for batch sizes that range from 2-20,000 liters of cell culture and a proprietary disposable flow kit. The first system, planned for release in 2020, is a pilot scale unit for purification of 50 to 500 liters of cell culture.
Previously, President and co-founder Joanna Pezzini developed the continuous purification lab at AstraZeneca along with co-founder Kevin Hill-Byrne and board member Lindsay Arnold. “We are developing the system we wished we had available to us, but didn’t. We wanted to create a complete package so that each company doesn’t need to develop an entire system from the ground up.”
Kevin Hill-Byrne will lead the automation efforts, a significant undertaking for an end-to-end system. All process steps need to not only work independently, but in sync with all other stages of the system to achieve a consistent mass flow rate from the bioreactor through to the final UFDF steps. “I am thrilled to have Kevin working on this project – his automation experience is practically tailored to our company’s needs,” said Joanna Pezzini.
Recent Post
-
PAK BioSolutions Announces Grant from NCATS, FDA, CDC
-
Patent Granted for PAK Flow Kit
-
Continuous Processes Reduce Equipment Size and Cost
-
Reduce Consumable Expenses with Continuous Purification
-
Productivity - What is it and how do we improve it?
-
PAK BioSolutions Featured in GEN News
-
First PAK System Delivered to HQ
-
PAK BioSolutions Submits Patent Application for Solid, Single Use Flow Kit
-
PAK BioSolutions Founded
NOW AVAILABLE Pilot Scale PAK System
Demo, lease or purchase The PAK System continuous manufacturing equipment. Receive your custom quote now.
Request quote